In 2023, the Europe AIDS Clinical Society recommended guidelines for initiating ART in patients with TBM as follows [44]: in persons with CD4 counts < 50 cells/μL, ART should be initiated within the first 2 weeks after initiation of tuberculosis treatment, while ART initiation should be delayed for 4 weeks in all other cases. This evidence concerns the gene CD4 and tuberculosis.